People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biommune Technologies Inc. | — | Biotechnology | Pre-Seed | $600K | $33.1M | 2015 |
| Cava Healthcare Inc. | — | Healthtech | Pre-Seed | $189K | $6.5M | 2019 |
TERRY PEARSON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside TERRY PEARSON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Karoly Nikolich | 1 | 3 |
| Michael Hutchison | 1 | 2 |
| TAMMY GILLIS | 1 | 1 |
| ADRIAN WADE | 1 | 1 |
| WILLIAM ZALM | 1 | 1 |
| WILFRED JEFFRIES | 1 | 1 |
| LEIGH ANDERSON | 1 | 1 |
| ROSLYN RITCHIE-DERRIEN | 1 | 1 |
| PATRICK W. GRAY | 1 | 1 |
| Reinhard Gabathuler | 1 | 1 |
| JENS BIERTUMPEL | 1 | 1 |
| Judi Dalling | 1 | 1 |
| Rob Hutchison | 1 | 1 |
| PETER FIELD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.